1. Conway, J. G., Andrews, R. C., Beaudet, B., Bickett, D. M., Boncek, V., Brodie, T. A., Clark, R. L., Crumrine, R. C., Leenitzer, M. A., McDougald, D. L., Han, B., Hedeen, K., Lin, P., Milla, M., Moss, M., Pink, H., Rabinowitz, M. H., Tippin, T., Scates, P. W., Selph, J., Stimpson, S. A., Warner, J., and Becherer, J. D., Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.J. Pharmacol. Exp. Ther., 298, 900–908 2001.
2. Gongora, L., Manez, S., Giner, R. M., Recio, M. C., and Rios, J. L., On the activity of trifluoperazine and palmitoylcarnitine in mice: delayed hypersensitivity models.Life Sci., 66, L183–188 2000.
3. Gorgun, G., Miller, K. B., and Foss, F. M., Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease.Blood, 100, 941–947 2002.
4. Han, S. B., Park, S. H., Jeon, Y. J., Kim, Y K., Kim, H. M., and Yang, K. H., Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.J. Pharmacol. Exp. Ther., 299, 415–425 2001.
5. Jeong, H. J., Hong, S. H., Kim, S. C., Park, E. J., Jang, C. H., Kim, K. S., and Kim, H. M., Effects of Allergina on the treatment of otitis media with effusions.Inflammation, 26, 89–95 2002.